• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于改善脑血栓形成微循环和神经功能的剪切力-活性氧顺序响应药物递送系统。

Shear force-ROS sequential responsive drug delivery system for improving cerebral thrombosis microcirculation and neurological function.

作者信息

Zhang Huijuan, Wang Jingjing, Tian Yingmei, Wang Chaoqun, Hou Lin

机构信息

School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China; Henan Key Laboratory of Nanomedicine for Targeting Diagnosis and Treatment, Zhengzhou, China.

School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.

出版信息

J Control Release. 2025 Feb 10;378:195-208. doi: 10.1016/j.jconrel.2024.12.005. Epub 2024 Dec 13.

DOI:10.1016/j.jconrel.2024.12.005
PMID:39653151
Abstract

The ischemic strokes seriously threaten human health with high incidence and disability rates. Cerebral embolism and impaired brain function are the two major clinical features of this disease. Therefore, rapid restoration of cerebral blood supply and synchronous improvement of impaired neurological function is the key to treating strokes. Herein, based on the microenvironment of cerebral thrombosis and pathological characteristics of damaged neurons, we constructed a shear force and reactive oxygen species (ROS) dual-responsive system (UK@Fuc/CDPC-PTPCS) for sequential targeted delivery of thrombolytic agent urokinase (UK) and neuroprotective drug cytosolic choline (CDPC). Results proved that after intravenous administration, UK@Fuc/CDPC-PTPCS can quickly locate to cerebral thrombosis site via the active recognition capability of fucoidan (Fuc) to P-selectin overexpressed on activated platelets. Subsequently, the sharply increased blood shear force separated the core-shell structure by breaking the host-guest interaction of β-cyclodextrin (β-CD), so the UK loaded in the shell was first released to rapid thrombolysis and then restored cerebral blood supply. Afterward, the stroke homing peptide (SHp) modified CDPC-PTPCS core actively recognized ischemic damaged neuronal cells. Then high intracellular ROS triggered CDPC release at specific sites to exert neuroprotective effects. This study offered a new therapeutic strategy for ischemic stroke.

摘要

缺血性中风发病率和致残率高,严重威胁人类健康。脑栓塞和脑功能受损是该疾病的两个主要临床特征。因此,快速恢复脑供血并同步改善受损神经功能是治疗中风的关键。在此,基于脑血栓的微环境和受损神经元的病理特征,我们构建了一种剪切力和活性氧(ROS)双响应系统(UK@Fuc/CDPC-PTPCS),用于依次靶向递送溶栓剂尿激酶(UK)和神经保护药物胞质胆碱(CDPC)。结果证明,静脉给药后,UK@Fuc/CDPC-PTPCS可通过岩藻糖胶(Fuc)对活化血小板上过度表达的P-选择素的主动识别能力快速定位到脑血栓部位。随后,急剧增加的血液剪切力通过破坏β-环糊精(β-CD)的主客体相互作用分离核壳结构,因此壳层中负载的UK首先释放以快速溶栓,然后恢复脑供血。之后,中风归巢肽(SHp)修饰的CDPC-PTPCS核心主动识别缺血受损神经元细胞。然后高细胞内ROS触发CDPC在特定部位释放以发挥神经保护作用。本研究为缺血性中风提供了一种新的治疗策略。

相似文献

1
Shear force-ROS sequential responsive drug delivery system for improving cerebral thrombosis microcirculation and neurological function.用于改善脑血栓形成微循环和神经功能的剪切力-活性氧顺序响应药物递送系统。
J Control Release. 2025 Feb 10;378:195-208. doi: 10.1016/j.jconrel.2024.12.005. Epub 2024 Dec 13.
2
Thrombin-Responsive and Sequential Targeted Nanoplatform for Synergistic Thrombolysis Therapy.用于协同溶栓治疗的凝血酶响应性和顺序靶向纳米平台
ACS Appl Mater Interfaces. 2025 Mar 19;17(11):16696-16707. doi: 10.1021/acsami.5c01658. Epub 2025 Mar 7.
3
Shear force and cholesterol affinity responsive drug delivery system for treating inflammation and abnormal lipid metabolism in atherosclerosis.用于治疗动脉粥样硬化中炎症和脂质代谢异常的剪切力和胆固醇亲和力响应型药物递送系统
J Control Release. 2025 May 10;381:113633. doi: 10.1016/j.jconrel.2025.113633. Epub 2025 Mar 19.
4
Bioengineered Boronic Ester Modified Dextran Polymer Nanoparticles as Reactive Oxygen Species Responsive Nanocarrier for Ischemic Stroke Treatment.硼酯修饰葡聚糖聚合物纳米粒子作为活性氧响应型纳米载体用于缺血性脑卒中治疗
ACS Nano. 2018 Jun 26;12(6):5417-5426. doi: 10.1021/acsnano.8b00477. Epub 2018 Jun 5.
5
Enhanced neuroprotection and reduced hemorrhagic incidence in focal cerebral ischemia of rat by low dose combination therapy of urokinase and topiramate.
Neuropharmacology. 2000 Mar 3;39(5):881-8. doi: 10.1016/s0028-3908(99)00248-8.
6
Intra-arterial reteplase compared to urokinase for thrombolytic recanalization in acute ischemic stroke.急性缺血性卒中动脉内瑞替普酶与尿激酶溶栓再通效果的比较
AJNR Am J Neuroradiol. 2006 Apr;27(4):769-73.
7
Usefulness of postischemic thrombolysis with or without neuroprotection in a focal embolic model of cerebral ischemia.在局灶性脑缺血栓塞模型中,缺血后溶栓联合或不联合神经保护的效用。
J Neurosurg. 2000 May;92(5):841-7. doi: 10.3171/jns.2000.92.5.0841.
8
Systemic thrombolysis for cerebral venous and dural sinus thrombosis: a systematic review.用于脑静脉和硬脑膜窦血栓形成的全身溶栓治疗:一项系统评价
Cerebrovasc Dis. 2014;37(1):43-50. doi: 10.1159/000356840. Epub 2013 Dec 18.
9
PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.PROACT:重组尿激酶经动脉直接给药治疗急性大脑中动脉卒中的II期随机试验。PROACT研究人员。急性脑血栓栓塞症中的普洛赛克(重组尿激酶)。
Stroke. 1998 Jan;29(1):4-11. doi: 10.1161/01.str.29.1.4.
10
The protective effect of polyethylene glycol-conjugated urokinase nanogels in rat models of ischemic stroke when administrated outside the usual time window.聚乙二醇修饰的尿激酶纳米凝胶在常规时间窗之外的缺血性脑卒中大鼠模型中的保护作用。
Biochem Biophys Res Commun. 2020 Mar 19;523(4):887-893. doi: 10.1016/j.bbrc.2020.01.032. Epub 2020 Jan 16.